US Patent Issued to Vanderbilt University, The University of Mississippi Medical Center on June 17 for "Citrulline for treatment of sickle cell crisis" (Maryland, District Of Columbia, Arkansas Inventors)

ALEXANDRIA, Va., June 19 -- United States Patent no. 12,329,732, issued on June 17, was assigned to Vanderbilt University (Nashville, Tenn.) and The University of Mississippi Medical Center (Jackson, Miss.).

"Citrulline for treatment of sickle cell crisis" was invented by Marshall L. Summar (Washington), Frederick E. Barr (Little Rock, Ark.) and Suvankar Majumdar (Rockville, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method for administration of citrulline for the treatment of sickle cell disease and other complications of sickle cell disease thereof."

The patent was filed on June 3, 2022, under Application No. 17/832,058.

*For further information, including images, charts and tables, please visi...